163 related articles for article (PubMed ID: 11364442)
1. Nelfinavir: fourth protease inhibitor approved.
Crit Path AIDS Proj; 1997; (No 32):31-2. PubMed ID: 11364442
[TBL] [Abstract][Full Text] [Related]
2. FDA approves nelfinavir. Food and Drug Administration.
GMHC Treat Issues; 1997 Mar; 11(3):8. PubMed ID: 11364277
[TBL] [Abstract][Full Text] [Related]
3. Nelfinavir (Viracept) approved: fourth protease inhibitor available.
James JS
AIDS Treat News; 1997 Mar; (No 267):1-2. PubMed ID: 11364249
[TBL] [Abstract][Full Text] [Related]
4. New drug approved to treat HIV.
Treat Rev; 1997 Apr; (No 24):5. PubMed ID: 11364284
[TBL] [Abstract][Full Text] [Related]
5. Fourth protease inhibitor hits the market.
AIDS Alert; 1997 May; 12(5):59-60. PubMed ID: 11364224
[TBL] [Abstract][Full Text] [Related]
6. Pediatric treatments.
AIDS Policy Law; 1997 Apr; 12(6):12. PubMed ID: 11364179
[TBL] [Abstract][Full Text] [Related]
7. Nelfinavir (Viracept) moves up the ranks.
Grodeck B
Posit Aware; 1997; 8(2):16-7. PubMed ID: 11364452
[TBL] [Abstract][Full Text] [Related]
8. Newly approved PI provides treatment options.
AIDS Alert; 1997 Jun; 12(6):68-9. PubMed ID: 11364360
[TBL] [Abstract][Full Text] [Related]
9. Nelfinavir - major trial results at retroviruses conference.
AIDS Treat News; 1997 Feb; (No 265):3-4. PubMed ID: 11364240
[TBL] [Abstract][Full Text] [Related]
10. Nelfinavir (Viracept).
Baker R; Bowers M
BETA; 1997 Mar; ():5. PubMed ID: 11364528
[TBL] [Abstract][Full Text] [Related]
11. FDA rapidly approves HIV protease inhibitors for children.
Fox JL
Nat Biotechnol; 1997 May; 15(5):404. PubMed ID: 9131607
[No Abstract] [Full Text] [Related]
12. Nelfinavir at six months.
PI Perspect; 1997 Mar; (No 21):11-2. PubMed ID: 11364207
[TBL] [Abstract][Full Text] [Related]
13. Phase II/III Trials of Viracept start.
AIDS Patient Care STDS; 1996 Jun; 10(3):187. PubMed ID: 11361632
[No Abstract] [Full Text] [Related]
14. Nelfinavir is number 4 -- but should it bat cleanup, or lead off?
Mascolini M
J Int Assoc Physicians AIDS Care; 1997 Jun; 3(6):17-21. PubMed ID: 11364427
[TBL] [Abstract][Full Text] [Related]
15. Nelfinavir combination therapy: ten-month report.
AIDS Treat News; 1997 Apr; (No 269):3. PubMed ID: 11364253
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 protease inhibitors.
Deeks SG; Volberding PA
AIDS Clin Rev; 1997-1998; ():145-85. PubMed ID: 9305448
[No Abstract] [Full Text] [Related]
17. New protease inhibitor available through expanded access.
Posit Aware; 1996; 7(6):7. PubMed ID: 11363981
[TBL] [Abstract][Full Text] [Related]
18. Anti-HIV effects of Viracept persist during long periods of combination therapy.
Oncology (Williston Park); 1997 Jun; 11(6):915. PubMed ID: 9189946
[No Abstract] [Full Text] [Related]
19. Amprenavir, new protease inhibitor, approved.
James JS
AIDS Treat News; 1999 May; (No 318):1-3. PubMed ID: 11366454
[TBL] [Abstract][Full Text] [Related]
20. FDA approves 3TC and saquinavir. Food and Drug Administration.
Baker R
BETA; 1995 Dec; ():5, 9. PubMed ID: 11363011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]